MedPage Today on MSN
Off-label drug proves its mettle in relapsing multiple sclerosis
Rituximab and ocrelizumab go head to head in randomized trial ...
The Anne Arundel County resident recently announced his retirement because of complications surrounding a multiple sclerosis ...
Removal of tonsils and adenoids — adenotonsillotomy — is associated with an increased risk of developing and higher activity ...
Multiple sclerosis (MS) can have a substantial impact on many aspects of life beyond physical health, with 51% of people ...
2don MSN
Large multiple sclerosis brain cohort reveals biological differences linked to disease severity
Why does multiple sclerosis progress quickly in some people, while others remain stable for years? Researchers from the ...
Increasing the Ocrevus dose used in treating MS provided no additional benefit versus the approved regimen in trials with over 1,500 patients.
A lab study suggests cyclodextrins may help support myelin sheath repair in MS by reducing harmful fat buildup in immune cells.
Multiple sclerosis (MS) can have a substantial impact on many aspects of life beyond physical health, with 51% of people ...
India, June 28 -- Multiple sclerosis (MS) affects much more than physical health, often disrupting people's social lives, ...
A Perrysburg man living with multiple sclerosis is setting out on a journey across Ireland in hopes of breaking a Guinness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results